Press releases

GSK and Verily to establish Galvani Bioelectronics – a new company dedicated to the development of bioelectronic medicines

GSK (LSE/NYSE: GSK) today announced an agreement with Verily Life Sciences LLC (formerly Google Life Sciences), an Alphabet company, to form Galvani Bioelectronics to enable the research, development and commercialisation of bioelectronic medicines. GSK will hold a 55% equity interest in the new jointly owned company and Verily will hold 45%.

Read more - GSK and Verily to establish Galvani Bioelectronics – a new company dedicated to the development of bioelectronic medicines Read more